Internal Medicine, Cardiovascular Disease · Brewster, MA
NPI
1518919836
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
125 Underpass Rd
Brewster, MA, 02631
Phone (085) 876-3777
Groups this clinician bills Medicare through
Medicare paid, 2024
$733K
9,827 services
Medicare patients, 2024
1,738
Average age 78
Drug cost, 2024
$1.9M
8,509 prescriptions
Company payments, 2024
$83.28
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eleanor R Sullivan was code 99214 (office e&m - established), 2,702 times for 1,532 patients. In total Eleanor R Sullivan billed 9,827 services in 23 codes, and Medicare paid $733K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,702 | 1,532 | $95.73 | $259K |
| 93000 Electrocardiogram | Office | 2,653 | 1,611 | $11.12 | $29K |
| 93306 Echocardiography (TTE/TEE) | Office | 703 | 685 | $158.93 | $112K |
| 93793 Care Management/Coordination | Office | 660 | 33 | $8.78 | $5,795 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 578 | 289 | $104.90 | $61K |
| 93356 Echocardiography (TTE/TEE) | Office | 556 | 542 | $30.98 | $17K |
| 93015 Electrocardiogram | Office | 420 | 391 | $59.76 | $25K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 404 | 101 | $5.28 | $2,135 |
| 78452 Myocardial Perfusion Scan | Office | 292 | 292 | $360.35 | $105K |
| 93224 Electrocardiogram | Office | 225 | 220 | $55.74 | $13K |
| 99213 Office E&M - Established | Office | 176 | 151 | $73.09 | $13K |
| 99204 Office E&M - New | Office | 97 | 97 | $126.29 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 88 | 75 | $13.82 | $1,216 |
| 93229 Electrocardiogram | Office | 83 | 83 | $706.96 | $59K |
| 93228 Electrocardiogram | Office | 83 | 83 | $20.07 | $1,666 |
By year: 2022 $768K for 10,237 services; 2023 $785K for 10,627 services; 2024 $733K for 9,827 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eleanor R Sullivan prescribed most often to Medicare patients was Atorvastatin Calcium, with 799 prescriptions and refills. In total Eleanor R Sullivan wrote 8,509 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 799 | 2,280 | 241 | $12K |
| Metoprolol Succinate Generic | 784 | 2,251 | 237 | $16K |
| Eliquis Apixaban | 719 | 1,875 | 208 | $1.0M |
| Lisinopril Generic | 532 | 1,478 | 172 | $4,397 |
| Amlodipine Besylate Generic | 512 | 1,478 | 168 | $3,656 |
| Rosuvastatin Calcium Generic | 433 | 1,236 | 139 | $15K |
| Carvedilol Generic | 431 | 1,155 | 134 | $4,465 |
| Hydrochlorothiazide Generic | 339 | 917 | 127 | $1,453 |
| Losartan Potassium Generic | 335 | 926 | 109 | $4,168 |
| Xarelto Rivaroxaban | 301 | 792 | 89 | $419K |
| Spironolactone Generic | 222 | 647 | 79 | $2,225 |
| Clopidogrel Clopidogrel Bisulfate | 208 | 607 | 64 | $3,574 |
| Amiodarone Hcl Generic | 192 | 558 | 59 | $8,109 |
| Furosemide Generic | 186 | 478 | 69 | $988 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 174 | 510 | 59 | $6,564 |
Brand drugs: 1,323 claims; generic drugs: 7,186 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Eleanor R Sullivan $83.28 ($83.28 in general payments such as food, travel and fees) from 4 companies. The largest payer was Amgen Inc. with $32.42.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.